GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Therapeutic Solutions International Inc (OTCPK:TSOI) » Definitions » Gross Margin %

Therapeutic Solutions International (Therapeutic Solutions International) Gross Margin % : 54.17% (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Therapeutic Solutions International Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Therapeutic Solutions International's Gross Profit for the three months ended in Dec. 2023 was $0.01 Mil. Therapeutic Solutions International's Revenue for the three months ended in Dec. 2023 was $0.02 Mil. Therefore, Therapeutic Solutions International's Gross Margin % for the quarter that ended in Dec. 2023 was 54.17%.


The historical rank and industry rank for Therapeutic Solutions International's Gross Margin % or its related term are showing as below:

TSOI' s Gross Margin % Range Over the Past 10 Years
Min: -50   Med: 62.63   Max: 88.89
Current: 63.64


During the past 13 years, the highest Gross Margin % of Therapeutic Solutions International was 88.89%. The lowest was -50.00%. And the median was 62.63%.

TSOI's Gross Margin % is ranked better than
53.94% of 736 companies
in the Biotechnology industry
Industry Median: 59.655 vs TSOI: 63.64

Therapeutic Solutions International had a gross margin of 54.17% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Therapeutic Solutions International was 5.70% per year.


Therapeutic Solutions International Gross Margin % Historical Data

The historical data trend for Therapeutic Solutions International's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Therapeutic Solutions International Gross Margin % Chart

Therapeutic Solutions International Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 88.89 79.37 70.55 61.35 62.63

Therapeutic Solutions International Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -411.11 65.22 61.54 73.08 54.17

Competitive Comparison of Therapeutic Solutions International's Gross Margin %

For the Biotechnology subindustry, Therapeutic Solutions International's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Therapeutic Solutions International's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Therapeutic Solutions International's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Therapeutic Solutions International's Gross Margin % falls into.



Therapeutic Solutions International Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Therapeutic Solutions International's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=0.1 / 0.099
=(Revenue - Cost of Goods Sold) / Revenue
=(0.099 - 0.037) / 0.099
=62.63 %

Therapeutic Solutions International's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=0 / 0.024
=(Revenue - Cost of Goods Sold) / Revenue
=(0.024 - 0.011) / 0.024
=54.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Therapeutic Solutions International  (OTCPK:TSOI) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Therapeutic Solutions International had a gross margin of 54.17% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Therapeutic Solutions International Gross Margin % Related Terms

Thank you for viewing the detailed overview of Therapeutic Solutions International's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Therapeutic Solutions International (Therapeutic Solutions International) Business Description

Traded in Other Exchanges
N/A
Address
701 Wild Rose Lane, Elk City, ID, USA, 83525
Therapeutic Solutions International Inc focuses on immune modulation for the treatment of several specific diseases. It is engaged in developing a range of immune-modulatory agents to target certain cancers, improve maternal and fetal health, fight periodontal disease, and for daily health. The business divisions of the company are Nutraceutical Division which produces nutraceuticals. Its current product, QuadraMune, is a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone. Cellular Division obtained exclusive rights to a patented adult stem cell for the development of therapeutics in the area of chronic traumatic encephalopathy (CTE) and traumatic brain injury (TBI) and Lung Pathology (LP).
Executives
Thomas Ichim director 211 E. OSBORN RD, PHOENIX AZ 85012
Gerry B Berg officer: CFO 1658 AVENIDA LA POSTA, ENCINITAS CA 92024
Timothy G Dixon director, officer: Chairman, President, CEO 4093 OCEANSIDE BLVD., SUITE B, OCEANSIDE CA 92056
Barry Glassman officer: VP, Training & Education 2051 ELBOW LANE, ALLENTOWN PA 18103
James P Boyd director, 10 percent owner PO BOX 2145, RANCHO SANTA FE CA 92067

Therapeutic Solutions International (Therapeutic Solutions International) Headlines

From GuruFocus